V. Tyagi, M. Scordo, R.S. Yoon, F.A. Liporace, L.W. Greene, Revisiting the role of testosterone: Are we missing something? Rev. Urol. 19, 16–24 (2017). https://doi.org/10.3909/riu0716
Article PubMed PubMed Central Google Scholar
G. Navarro, C. Allard, W. Xu, F. Mauvais-Jarvis, The role of androgens in metabolism, obesity, and diabetes in males and females. Obesity 23, 713–9 (2015). https://doi.org/10.1002/oby.21033
Article CAS PubMed Google Scholar
W. Xu, J. Morford, F. Mauvais-Jarvis, Emerging role of testosterone in pancreatic β cell function and insulin secretion. J. Endocrinol. 240, R97–105 (2019). https://doi.org/10.1530/JOE-18-0573
W.T. Berg, M. Miner, Hypogonadism and metabolic syndrome: review and update. Curr. Opin. Endocrinol. Diab. Obes. 27, 404–10 (2020). https://doi.org/10.1097/MED.0000000000000582
K. Kumari, R. Kumar, A. Memon et al. Treatment with testosterone therapy in type 2 diabetic hypogonadal adult males: A systematic review and meta-analysis. Clin. Pract. 13, 454–69 (2023). https://doi.org/10.3390/clinpract13020041
Article PubMed PubMed Central Google Scholar
T.G. Travison, H.W. Vesper, E. Orwoll et al. Harmonized reference ranges for circulating testosterone levels in men of four cohort studies in the United States and Europe. J. Clin. Endocrinol. Metab. 102, 1161–73 (2017). https://doi.org/10.1210/jc.2016-2935
Article PubMed PubMed Central Google Scholar
G.A. Kanakis, C.P. Tsametis, D.G. Goulis, Measuring testosterone in women and men. Maturitas 125, 41–4 (2019). https://doi.org/10.1016/j.maturitas.2019.04.203
Article CAS PubMed Google Scholar
J.C.C. Kwong, Y. Krakowsky, E. Grober, Testosterone deficiency: A review and comparison of current guidelines. J. Sex. Med. 16, 812–20 (2019). https://doi.org/10.1016/j.jsxm.2019.03.262
J.P. Mulhall, L.W. Trost, R.E. Brannigan et al. Evaluation and management of testosterone deficiency: AUA guideline. J. Urol. 200, 423–32 (2018). https://doi.org/10.1016/j.juro.2018.03.115
C.A. Salter, J.P. Mulhall, Guideline of guidelines: testosterone therapy for testosterone deficiency. BJU Int. 124, 722–9 (2019). https://doi.org/10.1111/bju.14899
J. Anaissie, K.J. DeLay, W. Wang, G. Hatzichristodoulou, W.J. Hellstrom, Testosterone deficiency in adults and corresponding treatment patterns across the globe. Transl. Androl. Urol. 6, 183–91 (2017). https://doi.org/10.21037/tau.2016.11.16
Article PubMed PubMed Central Google Scholar
P. Gyawali, S.A. Martin, L.K. Heilbronn et al. The role of sex hormone-binding globulin (SHBG), testosterone, and other sex steroids, on the development of type 2 diabetes in a cohort of community-dwelling middle-aged to elderly men. Acta Diabetologica 55, 861–72 (2018). https://doi.org/10.1007/s00592-018-1163-6
Article CAS PubMed Google Scholar
M.S. Ccorahua-Ríos, N. Atamari-Anahui, I. Miranda-Abarca, A.B. Campero-Espinoza, E.A. Rondón-Abuhadba, C.J. Pereira-Victorio, Type 2 diabetes mellitus prevalence between 2005 and 2018 in population under 30 using data from the Ministry of Health of Peru. Medwave 19, e7723 (2019). https://doi.org/10.5867/medwave.2019.10.7723
American Diabetes Association Professional Practice Committee. 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2024. Diab. Care 47, S20–S42 (2024). https://doi.org/10.2337/dc24-S002.
M.W. O’Reilly, M. Glisic, B. Kumarendran et al. Serum testosterone, sex hormone-binding globulin and sex-specific risk of incident type 2 diabetes in a retrospective primary care cohort. Clin. Endocrinol. 90, 145–54 (2019). https://doi.org/10.1111/cen.13862
G. Corona, M. Monami, G. Rastrelli et al. Type 2 diabetes mellitus and testosterone: a meta-analysis study. Int. J. Androl. 34, 528–40 (2011). https://doi.org/10.1111/j.1365-2605.2010.01117.x
Article CAS PubMed Google Scholar
J. Zhang, X. Li, Z. Cai, H. Li, B. Yang, Association between testosterone with type 2 diabetes in adult males, a meta-analysis and trial sequential analysis. Aging Male 23, 607–18 (2020). https://doi.org/10.1080/13685538.2018.1557139
Article CAS PubMed Google Scholar
Q.M. Yao, B. Wang, X.F. An, J.A. Zhang, L. Ding, Testosterone level and risk of type 2 diabetes in men: a systematic review and meta-analysis. Endocr. Connect. 7, 220–31 (2018). https://doi.org/10.1530/EC-17-0253
Article CAS PubMed Google Scholar
Cochrane Handbook for Systematic Reviews of Interventions. Accessed December 27, 2023. https://training.cochrane.org/handbook/archive/v6.3
D. Moher, A. Liberati, J. Tetzlaff, D.G. Altman, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6, e1000097 (2009). https://doi.org/10.1371/journal.pmed.1000097
Article PubMed PubMed Central Google Scholar
B.J. Shea, B.C. Reeves, G. Wells et al. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ 358, j4008 (2017). https://doi.org/10.1136/bmj.j4008
Article PubMed PubMed Central Google Scholar
M. Karakas, S. Schäfer, S. Appelbaum et al. Testosterone levels and type 2 diabetes—no correlation with age, differential predictive value in men and women. Biomolecules 8, 76 (2018). https://doi.org/10.3390/biom8030076
Article CAS PubMed PubMed Central Google Scholar
S.A. Holmboe, T.K. Jensen, A. Linneberg et al. Low testosterone: A risk marker rather than a risk factor for type 2 diabetes. J. Clin. Endocrinol. Metab. 101, 3180–90 (2016). https://doi.org/10.1210/jc.2016-1778
Article CAS PubMed Google Scholar
M. Harrer, P. Cuijpers, T.A. Furukawa, D.D. Ebert. Welcome! | Doing Meta-Analysis in R. Accessed March 26, 2024. https://bookdown.org/MathiasHarrer/Doing_Meta_Analysis_in_R/
D.P. McKenzie, C. Thomas. Relative risks and odds ratios: Simple rules on when and how to use them. Eur J Clin Invest. Published online April 20, 2020:e13249. https://doi.org/10.1111/eci.13249
G.A. Wells, B. Shea, D. O’Connell et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Published online December 2021. https://www.ohri.ca/programs/clinical_epidemiology/oxford.asp
L. Lin, H. Chu, Quantifying publication bias in meta-analysis. Biometrics 74, 785–94 (2018). https://doi.org/10.1111/biom.12817
T.D. Stanley, H. Doucouliagos, J.P.A. Ioannidis, E.C. Carter, Detecting publication selection bias through excess statistical significance. Res Synth. Methods 12, 776–95 (2021). https://doi.org/10.1002/jrsm.1512
Article CAS PubMed Google Scholar
N. Meader, K. King, A. Llewellyn et al. A checklist designed to aid consistency and reproducibility of GRADE assessments: development and pilot validation. Syst. Rev. 3, 82 (2014). https://doi.org/10.1186/2046-4053-3-82
Article PubMed PubMed Central Google Scholar
A. Granholm, W. Alhazzani, M.H. Møller, Use of the GRADE approach in systematic reviews and guidelines. Br. J. Anaesth. 123, 554–9 (2019). https://doi.org/10.1016/j.bja.2019.08.015
S.M. Haffner, J. Shaten, M.P. Stem, G.D. Smith, L. Kuller, Low levels of sex hormone-binding globulin and testosterone predict the development of non-insulin-dependent diabetes mellitus in men. Am. J. Epidemiol. 143, 889–97 (1996). https://doi.org/10.1093/oxfordjournals.aje.a008832
Article CAS PubMed Google Scholar
R.K. Stellato, H.A. Feldman, O. Hamdy, E.S. Horton, J.B. McKinlay, Testosterone, sex hormone-binding globulin, and the development of type 2 diabetes in middle-aged men: prospective results from the Massachusetts male aging study. Diab. Care 23, 490–4 (2000). https://doi.org/10.2337/diacare.23.4.490
Comments (0)